This new identity represents a significant milestone in our company’s journey, from a biotech start-up to a clinical-stage biotech dedicated to developing curative therapies for untreated serious diseases.

Revital Rattenbach, the CEO of 4P-Pharma, stated: “The company’s new identity marks a new chapter in our evolution to become an integrated pharma company. This transformation injects a fresh wave of energy into our organization, highlighting our audacity, passion for science, and the dynamism of our teams.”